论文部分内容阅读
此前并不广为人知的青蒿素企业——华立集团,因屠呦呦获诺奖一时成为业内外关注的焦点获悉屠呦呦获得诺贝尔奖的当晚,汪力成竟辗转难眠。汪力成是浙江华立集团董事局主席,掌舵多家上市公司,其中,由其投资的青蒿素产业拥有完整的产业链,并掌握了全国70%的青蒿素原料。此前并不广为人知的青蒿素产业,因屠呦呦获诺奖一时成为业内外关注的焦点,"青蒿素合成难度比较大,目前临床用的是甲基青蒿素。所以国内只提供青蒿
Huoli Group, an artemisinin-based company that was not widely known before, was informed that Tu Hao’s Nobel Prize became a focus of attention both inside and outside the industry. Wang Licheng is Chairman of the Board of Directors of Zhejiang Holley Group. He heads several listed companies. Among them, the artemisinin industry invested by him has a complete industrial chain and he controls 70% of the country’s artemisinin raw materials. The artemisinin industry, which was not widely known before, has become the focus of attention within and outside the industry because of Tu Men’s winning of the Nobel Prize. “Artemisinin synthesis is more difficult and the current clinical use is methyl arteannuin. Therefore, only domestic Artemisia